Bristol-Myers Squibb Co. (BMY) Tops Q3 EPS by 2c; Affirms FY13 Outlook

October 23, 2013 7:30 AM

Bristol-Myers Squibb Co. (NYSE: BMY) reported Q3 EPS of $0.46, $0.02 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found